Table 5.
Univariate analysis and Cox model for progression-free survival (PFS) and overall survival (OS).
| Variables | PFS | OS | ||||
|---|---|---|---|---|---|---|
| Univariate | Cox model | Univariate | Cox model | |||
| p-Value | p-Value | HR [95% CI] | p-Value | p-Value | HR [95%CI] | |
| Age | 0.367 | 0.631 | ||||
| Sex | 0.167 | 0.432 | ||||
| ECOG | 0.641 | 0.048 | ||||
| Smoker | 0.222 | 0.254 | ||||
| Tumor site | 0.107 | 0.189 | ||||
| p16 | 0.049 | 0.023 | 0.82 [0.67–0.98] | 0.667 | ||
| Total SUVmax | 0.001 | 0.014 | 2.76 [1.25–5.89] | 0.071 | ||
| Total MTV | 0.057 | 0.017 | 0.018 | 3.86 [1.35–7.88] | ||
| CPS | 0.099 | |||||
| <1 | ||||||
| 1–20 | 0.087 | 0.88 [0.42–1.05] | ||||
| ≥20 | 0.002 | 0.004 | 0.68 [0.37–0.83] | |||
| Chemotherapy | 0.035 | 0.034 | 0.86 [0.67–0.99] | 0.032 | 0.077 | 0.98 [0.46–1.28] |
ECOG, Eastern Cooperative Oncology Group score; Total SUVmax, total max standard uptake value; Total MTV, total metabolic tumor volume; CPS, combined positive score.